References
- Akula SM, Hurley DJ, Wixon RL, Wang C, Chase CC. (2002). Effect of genistein on replication of bovine herpesvirus type 1. Am J Vet Res, 63, 1124–1128.
- Alarcón B, González ME, Carrasco L. (1984). Antiherpesvirus action of atropine. Antimicrob Agents Chemother, 26, 702–706.
- Amoros M, Simões CM, Girre L, Sauvager F, Cormier M. (1992). Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis. J Nat Prod, 55, 1732–1740.
- Bourne N, Bernstein DI, Stanberry LR. (1999). Civamide (cis-capsaicin) for treatment of primary or recurrent experimental genital herpes. Antimicrob Agents Chemother, 43, 2685–2688.
- Cafarchia C, De Laurentis N, Milillo MA, Losacco V, Puccini V. (1999). Antifungal activity of Apulia region propolis. Parassitologia, 41, 587–590.
- Chávez JH, Leal PC, Yunes RA, Nunes RJ, Barardi CR, Pinto AR, Simões CM, Zanetti CR. (2006). Evaluation of antiviral activity of phenolic compounds and derivatives against rabies virus. Vet Microbiol, 116, 53–59.
- Chiang LC, Chiang W, Chang MY, Ng LT, Lin CC. (2002). Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res, 55, 53–62.
- Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC. (2005). Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol, 32, 811–816.
- CLSI/NCCLS. (1996). Method for broth dilution antifungal susceptibility testing yeast; approved standard, M27-A, 15, 10. Tucson,AZ: National Committee for Clinical Laboratory Standards (now Clinical and Laboratory Standards Institute).
- CLSI/NCCLS. (2002). Approved standard, NCCLS document M100-S12. Wayne, PA: National Committee for Clinical Laboratory Standards (now Clinical and Laboratory Standards Institute).
- Cushnie TP, Lamb AJ. (2005). Antimicrobial activity of flavonoids. Int J Antimicrob Agents, 26, 343–356.
- De Bruyne T, Pieters L, Deelstra H, Vlietinck A. (1999). Condensed vegetable tannins: Biodiversity in structure and biological activities. Biochem System Ecol, 27, 445–459.
- Du J, He ZD, Jiang RW, Ye WC, Xu HX, But PP. (2003). Antiviral flavonoids from the root bark of Morus alba L. Phytochemistry, 62, 1235–1238.
- Evers DL, Chao CF, Wang X, Zhang Z, Huong SM, Huang ES. (2005). Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action. Antiviral Res, 68, 124–134.
- Ferenci P, Scherzer TM, Kerschner H, Rutter K, Beinhardt S, Hofer H, Schöniger-Hekele M, Holzmann H, Steindl-Munda P. (2008). Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. Gastroenterology, 135, 1561–1567.
- Fritz D, Venturi CR, Cargnin S, Schripsema J, Roehe PM, Montanha JA, von Poser GL. (2007). Herpes virus inhibitory substances from Hypericum connatum Lam., a plant used in southern Brazil to treat oral lesions. J Ethnopharmacol, 113, 517–520.
- Gonçalves JL, Leitão SG, Monache FD, Miranda MM, Santos MG, Romanos MT, Wigg MD. (2001). In vitro antiviral effect of flavonoid-rich extracts of Vitex polygama (Verbenaceae) against acyclovir-resistant herpes simplex virus type 1. Phytomedicine, 8, 477–480.
- Gul W, Hamann MT. (2005). Indole alkaloid marine natural products: An established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases. Life Sci, 78, 442–453.
- Iwasa K, Moriyasu M, Tachibana Y, Kim HS, Wataya Y, Wiegrebe W, Bastow KF, Cosentino LM, Kozuka M, Lee KH. (2001). Simple isoquinoline and benzylisoquinoline alkaloids as potential antimicrobial, antimalarial, cytotoxic, and anti-HIV agents. Bioorg Med Chem, 9, 2871–2884.
- Khan MT, Ather A, Thompson KD, Gambari R. (2005). Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res, 67, 107–119.
- Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S. (1999). Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol, 64, 235–240.
- Leone E. (2002). Use of yohimbine in preparation of immunobiologically active drugs (WO/2002/100406).
- Mayer KE, Myers RP, Lee SS. (2005). Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat, 12, 559–567.
- Monnet DL. (1998). Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol, 19, 552–559.
- Nowakowska Z. (2007). A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem, 42, 125–137.
- Ohnishi E, Bannai H. (1993). Quercetin potentiates TNF-induced antiviral activity. Antiviral Res, 22, 327–331.
- Orhana I, Özçelik B, Karaoglu T, Sener B. (2007). Antiviral and antimicrobial profiles of selected isoquinoline alkaloids from Fumaria and Corydalis species. Z Naturforsch, C, J Biosci, 62, 19–26.
- Özçelik B, Aslan M, Orhan I, Karaoglu T. (2005). Antibacterial, antifungal, and antiviral activities of the lipophylic extracts of Pistacia vera. Microbiol Res, 160, 159–164.
- Özçelik B, Orhan I, Toker G. (2006). Antiviral and antimicrobial assessment of some selected flavonoids. Z Naturforsch, C, J Biosci, 61, 632–638.
- Pradhan SC, Girish C. (2006). Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res, 124, 491–504.
- Paredes A, Alzuru M, Mendez J, Rodríguez-Ortega M. (2003). Anti-Sindbis activity of flavanones hesperetin and naringenin. Biol Pharm Bull, 26, 108–109.
- Ríos JL, Recio MC. (2005). Medicinal plants and antimicrobial activity. J Ethnopharmacol, 100, 80–84.
- Saller R, Meier R, Brignoli R. (2001). The use of silymarin in the treatment of liver diseases. Drugs, 61, 2035–2063.
- Schnitzler P, Schneider S, Stintzing FC, Carle R, Reichling J. (2008). Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus. Phytomedicine, 15, 1108–1116.
- Tsao TF, Newman MG, Kwok YY, Horikoshi AK. (1982). Effect of Chinese and western antimicrobial agents on selected oral bacteria. J Dent Res, 61, 1103–1106.
- Whitley RJ, Kimberlin DW, Roizman B. (1998). Herpes simplex viruses. Clin Infect Dis, 26, 541–53; quiz 554.
- Yamazaki Z, Tagaya I. (1980). Antiviral effects of atropine and caffeine. J Gen Virol, 50, 429–431.